A detailed history of Monarch Partners Asset Management LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 303,681 shares of ORGO stock, worth $971,779. This represents 0.25% of its overall portfolio holdings.

Number of Shares
303,681
Previous 301,480 0.73%
Holding current value
$971,779
Previous $977,000 16.48%
% of portfolio
0.25%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$2.48 - $3.43 $5,458 - $7,549
2,201 Added 0.73%
303,681 $816,000
Q2 2022

Jul 20, 2022

BUY
$4.74 - $8.15 $1.43 Million - $2.46 Million
301,480 New
301,480 $1.47 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $419M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.